Recent advances in the emerging therapeutic strategies for diabetic kidney diseases

W Huang, YY Chen, ZQ Li, FF He, C Zhang - International Journal of …, 2022 - mdpi.com
Diabetic kidney disease (DKD) is one of the most common causes of end-stage renal
disease worldwide. The treatment of DKD is strongly associated with clinical outcomes in …

What's new in the molecular mechanisms of diabetic kidney disease: recent advances

K Watanabe, E Sato, E Mishima, M Miyazaki… - International journal of …, 2022 - mdpi.com
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease, including end-
stage kidney disease, and increases the risk of cardiovascular mortality. Although the …

Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms

D Bhatia, SP Srivastava - Frontiers in Pharmacology, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is one of the leading causes of kidney failure, which leads to
end-stage renal disease (ESRD) and affects almost one-third of the total diabetic patients …

Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression

N Wang, C Zhang - International Journal of Molecular Sciences, 2024 - mdpi.com
Diabetic kidney disease (DKD) is a major cause of chronic kidney disease (CKD), and it
heightens the risk of cardiovascular incidents. The pathogenesis of DKD is thought to …

Pathomechanisms of Diabetic Kidney Disease

SK Sinha, SB Nicholas - Journal of Clinical Medicine, 2023 - mdpi.com
The worldwide occurrence of diabetic kidney disease (DKD) is swiftly rising, primarily
attributed to the growing population of individuals affected by type 2 diabetes. This surge …

Therapeutic strategies in the treatment of diabetic nephropathy-a translational medicine approach

IM Shah, SP Mackay, GA McKay - Current medicinal chemistry, 2009 - ingentaconnect.com
Type 2 Diabetes (T2D) is an important cause of renal dysfunction and the most common
cause of end-stage renal disease (ESRD). Diabetic nephropathy is also associated with an …

New strategies to tackle diabetic kidney disease

DB Demir, ME Cooper - Current Opinion in Nephrology and …, 2016 - journals.lww.com
New strategies to tackle diabetic kidney disease : Current Opinion in Nephrology and
Hypertension New strategies to tackle diabetic kidney disease : Current Opinion in …

[HTML][HTML] Diabetic nephropathy—a multifaceted target of new therapies

D Choudhury, M Tuncel, M Levi - Discovery medicine, 2010 - discoverymedicine.com
Diabetic nephropathy (DN) remains the most common cause for end stage renal disease
(ESRD) as the burden of diabetes increases worldwide. Nearly one-third of patients with …

Emerging therapeutics for the treatment of diabetic nephropathy

J Brenneman, J Hill, S Pullen - Bioorganic & Medicinal Chemistry Letters, 2016 - Elsevier
Diabetic nephropathy (DN) is the most common pathology contributing to the development
of chronic kidney disease (CKD). DN caused by hypertension and unmitigated inflammation …

[HTML][HTML] New progress in drugs treatment of diabetic kidney disease

J Wang, H Xiang, Y Lu, T Wu, G Ji - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Diabetic kidney disease (DKD) is not only one of the main complications of diabetes, but
also the leading cause of the end-stage renal disease (ESRD). The occurrence and …